Granza Bio (YC W24)

🗓 Founded 2023👥 6 employees💰 Last funded Jul 2024
Biotechnology Research🌐 granzabio.com
Website LinkedIn
Granza Bio is a biotechnology company developing a novel delivery “shell” platform to direct therapeutic cargo to specific tissues. For their lead candidate, Granza Bio is leveraging the discovery of the immune system’s powerful suite of weapons, “attack particles”. Utilizing their advanced delivery platform, they aim to target these "attack particles" against a range of diseases such as cancer, autoimmune disorders, and infections. Interested to know more?
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2023
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Granza Bio (YC W24)?
Granza Bio (YC W24) has 1 investors on record on gritt.io, including 1 early-stage backers.
When did Granza Bio (YC W24) last raise funding?
The most recent investment in Granza Bio (YC W24) recorded on gritt.io was in July 2024.
When was Granza Bio (YC W24) founded?
Granza Bio (YC W24) was founded in 2023.
What industry is Granza Bio (YC W24) in?
Granza Bio (YC W24) operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.